Eikonoklastes Therapeutics is an early-stage biopharmaceutical company focused on developing innovative treatments for neurodegenerative diseases, particularly amyotrophic lateral sclerosis (ALS)
Eikonoklastes Therapeutics is an early-stage biopharmaceutical company focused on developing innovative treatments for neurodegenerative diseases, particularly amyotrophic lateral sclerosis (ALS).